Skip to main content

Table 1 Base-Line Characteristics of the Patients

From: Prehospital lung ultrasound for the diagnosis of cardiogenic pulmonary oedema: a pilot study

Characteristic (n = 40)
Age - years
 - Median (IQRa) 74 (67–81)
 - Range 56–95
Sex – no. (%)
 - Male 14 (35.0)
Smoking status – no. (%)
 - Never smoked 5 (12.5)
 - Current smoker 9 (23.5)
 - Previous smoker 22 (55.0)
 - Unknown status 4 (10.0)
Medical history – no. (%)
 - COPD 21 (52.5)
 - Asthma 1 (2.5)
 - Interstitial lung disease 3 (7.5)
 - Coronary artery disease 13 (32.5)
 - Heart failure 4 (10.0)
 - Valvular heart disease 4 (10.0)
 - Arterial hypertension 19 (47.5)
 - Thromboembolic disease 4 (10.0)
 - Diabetes mellitus 8 (20.0)
 - Stroke 5 (12.5)
 - Current or previous malignancy 10 (25.0)
Medication at admission – no. (%)
 - Inhaled bronchodilators 20 (50.0)
 - Inhaled corticosteroids 16 (40.0)
 - Oral corticosteroids 7 (17.5)
 - Aspirin 11 (27.5)
 - Clopidogrel 3 (7.5)
 - Persantin 3 (7.5)
 - Anticoagulants 10 (25.0)
 - Beta-blockers 8 (20.0)
 - ACE inhibitorsb 12 (30.0)
 - Calcium-channel blockers 12 (30.0)
 - Diuretics 22 (55.0)
 - Digoxin 5 (12.5)
 - Amiodarone 2 (5.0)
  1. aInterquartile range (IQR) expressed as the 25 and 75th
  2. bACE inhibitors denotes angiotensin-converting-enzyme inhibitor and angiotensin receptor blocker